1,2-dimethylhydrazine decreases expression ISO RGD:735374 6480464 1, 2-Dimethylhydrazine results in decreased expression of BMPR2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BMPR2 mRNA CTD PMID:29097150 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of BMPR2 mRNA CTD PMID:20068009 17beta-estradiol multiple interactions ISO RGD:735373 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of BMPR2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions ISO RGD:735374 6480464 BMPR2 protein modified form inhibits the reaction [KITLG protein inhibits the reaction [FSHB protein results in increased abundance of Estradiol]] more ... CTD PMID:22366471 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735373 6480464 Tetrachlorodibenzodioxin results in increased expression of BMPR2 mRNA CTD PMID:12377990 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BMPR2 mRNA CTD PMID:30172648 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BMPR2 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735373 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of BMPR2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735374 6480464 Tetrachlorodibenzodioxin affects the expression of BMPR2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735374 6480464 Tetrachlorodibenzodioxin results in increased expression of BMPR2 mRNA CTD PMID:21354282 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression ISO RGD:735373 6480464 beta-methylcholine affects the expression of BMPR2 mRNA CTD PMID:21179406 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 Drugs more ... CTD PMID:17803470 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA CTD PMID:17803470 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:735374 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BMPR2 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BMPR2 mRNA CTD PMID:30071829 4,4'-diaminodiphenylmethane increases expression ISO RGD:735374 6480464 4, 4'-diaminodiphenylmethane results in increased expression of BMPR2 mRNA CTD PMID:18648102 aflatoxin B1 affects methylation ISO RGD:735373 6480464 Aflatoxin B1 affects the methylation of BMPR2 intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO RGD:735373 6480464 aflatoxin B2 affects the methylation of BMPR2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:735373 6480464 Tretinoin results in increased expression of BMPR2 mRNA CTD PMID:21934132 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BMPR2 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:735373 6480464 aristolochic acid I results in decreased expression of BMPR2 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:735374 6480464 Arsenic results in decreased expression of BMPR2 mRNA CTD PMID:19654921 arsane increases expression EXP 6480464 Arsenic results in increased expression of BMPR2 protein CTD PMID:28903487 arsane affects expression ISO RGD:735373 6480464 Arsenic affects the expression of BMPR2 protein CTD PMID:24675094 arsenic atom decreases expression ISO RGD:735374 6480464 Arsenic results in decreased expression of BMPR2 mRNA CTD PMID:19654921 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of BMPR2 protein CTD PMID:28903487 arsenic atom affects expression ISO RGD:735373 6480464 Arsenic affects the expression of BMPR2 protein CTD PMID:24675094 arsenite(3-) multiple interactions ISO RGD:735373 6480464 arsenite inhibits the reaction [G3BP1 protein binds to BMPR2 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:735373 6480464 Arsenic Trioxide results in increased expression of BMPR2 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO RGD:735373 6480464 Benzo(a)pyrene results in decreased expression of BMPR2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:735373 6480464 Benzo(a)pyrene affects the methylation of BMPR2 intron, Benzo(a)pyrene affects the methylation of BMPR2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:735374 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 benzo[b]fluoranthene decreases expression ISO RGD:735374 6480464 benzo(b)fluoranthene results in decreased expression of BMPR2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:735374 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 benzo[e]pyrene increases methylation ISO RGD:735373 6480464 benzo(e)pyrene results in increased methylation of BMPR2 intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BMPR2 mRNA CTD PMID:25181051 , PMID:29097150 bisphenol A increases expression ISO RGD:735374 6480464 bisphenol A results in increased expression of BMPR2 mRNA CTD PMID:35598803 bisphenol A decreases expression ISO RGD:735374 6480464 bisphenol A results in decreased expression of BMPR2 mRNA CTD PMID:33221593 butanal decreases expression ISO RGD:735373 6480464 butyraldehyde results in decreased expression of BMPR2 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:735374 6480464 Cadmium Chloride results in increased expression of BMPR2 mRNA CTD PMID:20883709 carbon nanotube decreases expression ISO RGD:735374 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube affects expression ISO RGD:735374 6480464 Nanotubes, Carbon affects the expression of BMPR2 mRNA CTD PMID:23845593 CGS 15943 increases expression ISO RGD:735373 6480464 9-chloro-2-(2-furyl)-(1 more ... CTD PMID:25633564 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of BMPR2 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:735374 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BMPR2 gene CTD PMID:20938992 chrysene multiple interactions ISO RGD:735374 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 clobetasol decreases expression ISO RGD:735374 6480464 Clobetasol results in decreased expression of BMPR2 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:735373 6480464 cobaltous chloride results in decreased expression of BMPR2 mRNA CTD PMID:19320972 cocaine increases expression EXP 6480464 Cocaine results in increased expression of BMPR2 mRNA CTD PMID:17898221 coumestrol multiple interactions ISO RGD:735373 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crotonaldehyde decreases expression ISO RGD:735373 6480464 2-butenal results in decreased expression of BMPR2 mRNA CTD PMID:20471460 cyclosporin A decreases expression ISO RGD:735373 6480464 Cyclosporine results in decreased expression of BMPR2 mRNA CTD PMID:25562108 , PMID:27989131 dextran sulfate multiple interactions ISO RGD:735374 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BMPR2 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:735373 6480464 Arsenic Trioxide results in increased expression of BMPR2 mRNA CTD PMID:20458559 diuron decreases expression EXP 6480464 Diuron results in decreased expression of BMPR2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:735373 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMPR2 mRNA CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:735373 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA CTD PMID:19167446 ethanol increases expression ISO RGD:735374 6480464 Ethanol results in increased expression of BMPR2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:735374 6480464 Ethanol affects the expression of and affects the splicing of BMPR2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:735373 6480464 Ethyl Methanesulfonate results in increased expression of BMPR2 mRNA CTD PMID:23649840 fenfluramine increases response to substance ISO RGD:735373 6480464 BMPR2 gene mutant form results in increased susceptibility to Fenfluramine CTD PMID:12358323 fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of BMPR2 mRNA] CTD PMID:21619414 folic acid multiple interactions ISO RGD:735374 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BMPR2 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:735374 6480464 Folic Acid results in decreased expression of BMPR2 mRNA CTD PMID:25629700 fosinopril multiple interactions EXP 6480464 Fosinopril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA] CTD PMID:17803470 hydrogen cyanide increases expression ISO RGD:735374 6480464 Hydrogen Cyanide results in increased expression of BMPR2 mRNA CTD PMID:33914522 iloprost multiple interactions ISO RGD:735373 6480464 Iloprost inhibits the reaction [BMPR2 gene mutant form results in decreased expression of ID1 protein] CTD PMID:20522807 kenpaullone increases expression ISO RGD:735373 6480464 kenpaullone results in increased expression of BMPR2 mRNA CTD PMID:25633564 L-methionine multiple interactions ISO RGD:735374 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BMPR2 gene CTD PMID:20938992 mercury atom increases expression ISO RGD:735373 6480464 Mercury results in increased expression of BMPR2 mRNA CTD PMID:19937285 mercury dichloride decreases expression ISO RGD:735373 6480464 Mercuric Chloride results in decreased expression of BMPR2 mRNA CTD PMID:27188386 mercury(0) increases expression ISO RGD:735373 6480464 Mercury results in increased expression of BMPR2 mRNA CTD PMID:19937285 methacholine chloride multiple interactions ISO RGD:735374 6480464 BMPR2 protein affects the susceptibility to [Methacholine Chloride co-treated with Antigens, Dermatophagoides] CTD PMID:22427841 methapyrilene increases methylation ISO RGD:735373 6480464 Methapyrilene results in increased methylation of BMPR2 intron CTD PMID:30157460 methidathion decreases expression ISO RGD:735374 6480464 methidathion results in decreased expression of BMPR2 mRNA CTD PMID:34813904 methylmercury chloride decreases expression ISO RGD:735373 6480464 methylmercuric chloride results in decreased expression of BMPR2 mRNA CTD PMID:28001369 miconazole decreases expression ISO RGD:735374 6480464 Miconazole results in decreased expression of BMPR2 mRNA CTD PMID:27462272 monocrotaline multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of BMPR2 mRNA] CTD PMID:21619414 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of BMPR2 mRNA, Monocrotaline results in decreased expression of BMPR2 protein CTD PMID:20522807 more ... nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of BMPR2 mRNA, nitrofen results in decreased expression of BMPR2 protein CTD PMID:23780850 ozone multiple interactions ISO RGD:735374 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BMPR2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:735373 6480464 Acetaminophen results in increased expression of BMPR2 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:735373 6480464 perfluorooctane sulfonic acid results in decreased expression of BMPR2 mRNA CTD PMID:27153767 phenylmercury acetate multiple interactions ISO RGD:735373 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMPR2 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:735373 6480464 potassium chromate(VI) results in decreased expression of BMPR2 mRNA CTD PMID:22714537 potassium cyanide increases expression ISO RGD:735374 6480464 Potassium Cyanide results in increased expression of BMPR2 mRNA CTD PMID:33914522 resveratrol multiple interactions ISO RGD:735373 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of BMPR2 mRNA CTD PMID:19167446 Rutecarpine decreases expression ISO RGD:735373 6480464 rutecarpine results in decreased expression of BMPR2 mRNA CTD PMID:25633564 SB 431542 multiple interactions ISO RGD:735373 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMPR2 mRNA CTD PMID:27188386 silver atom increases expression ISO RGD:735373 6480464 Silver results in increased expression of BMPR2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:735373 6480464 Silver results in increased expression of BMPR2 mRNA CTD PMID:26014281 simvastatin affects expression ISO RGD:735373 6480464 Simvastatin affects the expression of BMPR2 mRNA CTD PMID:16297860 simvastatin increases stability ISO RGD:735373 6480464 Simvastatin results in increased stability of BMPR2 mRNA CTD PMID:16297860 simvastatin increases expression ISO RGD:735373 6480464 Simvastatin results in increased expression of BMPR2 protein CTD PMID:16297860 sodium arsenite increases expression ISO RGD:735374 6480464 sodium arsenite results in increased expression of BMPR2 mRNA CTD PMID:20883709 sunitinib increases expression ISO RGD:735373 6480464 Sunitinib results in increased expression of BMPR2 mRNA CTD PMID:31533062 taurine decreases expression ISO RGD:735373 6480464 Taurine results in decreased expression of BMPR2 mRNA CTD PMID:16579726 testosterone increases expression ISO RGD:735373 6480464 Testosterone results in increased expression of BMPR2 mRNA CTD PMID:34719554 testosterone increases expression ISO RGD:735374 6480464 Testosterone deficiency results in increased expression of BMPR2 mRNA CTD PMID:33848595 tetrachloroethene increases expression ISO RGD:735374 6480464 Tetrachloroethylene results in increased expression of BMPR2 mRNA CTD PMID:28973375 tetraphene multiple interactions ISO RGD:735374 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:735374 6480464 titanium dioxide results in decreased expression of BMPR2 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:735374 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BMPR2 mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:735374 6480464 titanium dioxide results in increased expression of BMPR2 mRNA CTD PMID:29264374 troglitazone decreases expression ISO RGD:735374 6480464 troglitazone results in decreased expression of BMPR2 mRNA CTD PMID:28973697 urethane increases expression ISO RGD:735373 6480464 Urethane results in increased expression of BMPR2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:735374 6480464 Valproic Acid affects the expression of BMPR2 mRNA CTD PMID:17292431 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of BMPR2 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of BMPR2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:735373 6480464 Valproic Acid results in increased expression of BMPR2 mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of BMPR2 mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:735373 6480464 vorinostat results in decreased expression of BMPR2 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:735373 6480464 vorinostat results in increased expression of BMPR2 mRNA CTD PMID:26272509 zoledronic acid increases expression ISO RGD:735373 6480464 zoledronic acid results in increased expression of BMPR2 mRNA CTD PMID:20977926